HSP90AB1 and lung adenocarcinoma: Furthermore, the identification of molecular con-text-dependent proteins proposed as potential biomarkers of response would facilitate monitoring outcomes in patients with lung adenocarcinoma following treatment with HSP90 inhibitors.